Showing results (221-230 of 386) with videos related to

Sort By:
Pageof 39
Journal of Virological Methods|May 7, 2014
TaqMan real time RT-PCR assays for detecting ferret innate and adaptive immune responsesLouise A Carolan, Jeff Butler, Steve Rockman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 13, 2022
Trend in Sensitivity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Serology One Year After Mild and Asymptomatic Coronavirus Disease 2019 (COVID-19): Unpacking Potential Bias in Seroprevalence StudiesChristopher R Bailie, Yeu Yang Tseng, Louise Carolan, et al.
Chemosphere|July 18, 2015
Biomonitoring of polycyclic aromatic hydrocarbons exposure in small groups of residents in Brisbane, Australia and Hanoi, Vietnam, and those travelling between the two citiesPhong K Thai, Zheng Li, Andreas Sjödin, et al.
The Journal of Infectious Diseases|August 29, 2014
Live attenuated and inactivated influenza vaccines in childrenNatalia A Ilyushina, Brenda C Haynes, Anne G Hoen, et al.
Viruses|December 23, 2022
Heparin Inhibits SARS-CoV-2 Replication in Human Nasal Epithelial CellsLeo Yi Yang Lee, Randy Suryadinata, Conor McCafferty, et al.
Vaccine|October 30, 2023
Superior immunogenicity of mRNA over adenoviral vectored COVID-19 vaccines reflects B cell dynamics independent of anti-vector immunity: Implications for future pandemic vaccinesYi Liu, Stephany Sánchez-Ovando, Louise Carolan, et al.
Vaccine|May 26, 2009
A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adultsKawsar R Talaat, Ruth A Karron, Karen A Callahan, et al.
Frontiers in Immunology|July 18, 2019
Recalling the Future: Immunological Memory Toward Unpredictable Influenza VirusesMaria Auladell, Xiaoxiao Jia, Luca Hensen, et al.
Nature Communications|March 4, 2021
Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaquesHyon-Xhi Tan, Jennifer A Juno, Wen Shi Lee, et al.
Influenza and Other Respiratory Viruses|November 4, 2024
Inno4Vac Workshop Report Part 1: Controlled Human Influenza Virus Infection Model (CHIVIM) Strain Selection and Immune Assays for CHIVIM Studies, November 2021, MHRA, UKJoanna Waldock, Rebecca J Cox, Christopher Chiu, et al.
Pageof 39